Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma

Area of Science:

• Immunology
• Oncology
• Virology

Background:

• Acquired Immunodeficiency Syndrome (AIDS) and Kaposi's Sarcoma (KS) present complex immune alterations.
• Accurate prognostic markers are crucial for managing AIDS-KS patients.

Purpose of the Study:

• To identify key immunological parameters for prognostically classifying immune alterations in AIDS-KS patients.
• To determine the prognostic significance of immunological markers compared to clinical staging.

Main Methods:

• Quantitative assessment of 16 immunological parameters in 97 AIDS-KS patients.
• Correlation analysis between immunological parameters and patient survival.
• Comparison of immunological prognostic value against tumor stage and clinical status.

Main Results:

• Reduced T4 (T helper-inducer) cell counts and T4-T8 ratios strongly correlated with prognosis.
• T4 levels >300/microL and T4-T8 ratio >0.5 indicated good prognosis (85-95% 12-month survival).
• T4 levels <100/microL or T4-T8 ratio <0.2 indicated poor prognosis (<25% 12-month survival).
• Reduced proliferative capacity, increased OKT10, elevated IgA, and immune complexes also correlated with prognosis.
• Other parameters like T8 cells, NK activity, and IgM levels lacked prognostic significance.

Conclusions:

• T4 cell counts and T4-T8 ratios are independent and significant prognostic indicators in AIDS-KS.
• Immunological classification offers valuable prognostic information beyond traditional clinical staging.
• Specific immune markers can predict survival outcomes in patients with AIDS-KS.